args

Universal healthcare stifles innovation

Profits drive innovation. That’s the long and short of it. Medical care is not exception, albeit the situation is a bit more complicated in this case. The US’s current system has a marketplace of different private insurers capable of making individual and often different decisions on how and which procedures they’ll choose to cover. Their decisions are something that helps shape and drive new and different practices in hospitals. A simple example is one of virtual colonoscopies. Without getting into the nitty gritty, they often require follow up procedures, yet are very popular with patients. Some insurers value the first, some the other, but none have the power to force the health care providers to choose one or the other. They’re free to decide for themselves, innovate with guidelines, even new procedures. Those are then communicated back to insurers, influencing them in turn and completing the cycle. What introducing a single-payer universal health coverage would do is introduce a single overwhelming player into this field – the government. Since we have seen how the insurer can often shape the care, what such a monopoly does is opens up the possibility of top-down mandates as to what this care Some insurers value the first, some the other, but none have the power to force the health care providers to choose one or the other. They’re free to decide for themselves, innovate with guidelines, even new procedures. Those are then communicated back to insurers, influencing them in turn and completing the cycle. What introducing a single-payer universal health coverage would do is introduce a single overwhelming player into this field – the government. Since we have seen how the insurer can often shape the care, what such a monopoly does is opens up the possibility of top-down mandates as to what this care Those are then communicated back to insurers, influencing them in turn and completing the cycle. What introducing a single-payer universal health coverage would do is introduce a single overwhelming player into this field – the government. Since we have seen how the insurer can often shape the care, what such a monopoly does is opens up the possibility of top-down mandates as to what this care should be. With talk of “comparative effectiveness research”, tasked with finding optimal cost-effective methods of treatment, the process has already begun.[1] [1] Wall Street Journal, How Washington Rations, published 5/19/2009, http://online.wsj.com/article/SB124268737705832167.html#mod=djemEditorialPage, accessed 9/18/2011